Michael Anderson
@lexhumana.bsky.social
Global health enthusiast. CEO of www.medaccess.org using innovative finance to drive improved access and affordability of medicines in underserved communities. Formerly CIFF, DFID, Bazian, BIICL, LSE, SOAS. Brightonian fan of BHAFC.
Reposted by Michael Anderson
IAVI announces first vaccinations in TB vaccine clinical trial: We are grateful to the trial funders: Open Philanthropy, the Gates Foundation, and the German Federal Ministry of Education and Research through the KfW Development Bank
www.iavi.org/press-releas...
www.iavi.org/press-releas...
IAVI and Biofabri/Zendal announce first vaccinations in the IMAGINE clinical trial, a large-scale safety and efficacy trial of the tuberculosis vaccine candidate MTBVAC
MTBVAC is a tuberculosis vaccine candidate for prevention of TB disease in people with latent TB infection.
www.iavi.org
February 26, 2025 at 6:43 PM
IAVI announces first vaccinations in TB vaccine clinical trial: We are grateful to the trial funders: Open Philanthropy, the Gates Foundation, and the German Federal Ministry of Education and Research through the KfW Development Bank
www.iavi.org/press-releas...
www.iavi.org/press-releas...
Like many leaders, I look forward to the annual staff survey results with a mix of excitement and dread. This year the results were the best we've had at medaccess.org
Thanks to my highly talented colleagues who bring empathy and dedication to work every day. I am blessed to work here.
Thanks to my highly talented colleagues who bring empathy and dedication to work every day. I am blessed to work here.
December 11, 2024 at 7:35 AM
Like many leaders, I look forward to the annual staff survey results with a mix of excitement and dread. This year the results were the best we've had at medaccess.org
Thanks to my highly talented colleagues who bring empathy and dedication to work every day. I am blessed to work here.
Thanks to my highly talented colleagues who bring empathy and dedication to work every day. I am blessed to work here.
The new Access to Medicines Index was published last week. Which pharmaceutical companies are taking action to improve access to products in LMICs? Novartis, GSK, Sanofi top the list. But worrying trends. See accesstomedicinefoundation.org #MedSky #Globalhealth #AccesstoMedicines
November 25, 2024 at 9:08 AM
The new Access to Medicines Index was published last week. Which pharmaceutical companies are taking action to improve access to products in LMICs? Novartis, GSK, Sanofi top the list. But worrying trends. See accesstomedicinefoundation.org #MedSky #Globalhealth #AccesstoMedicines
Reposted by Michael Anderson
Scientists found community on Twitter and stayed because they feared the platform would be full of misinformation if they left.
But Bluesky is now the center of online #medsky and science conversation. @katiepalmer.bsky.social has more on scientists' hopes, dreams, and fears for social media:
🩺🧪🧫
But Bluesky is now the center of online #medsky and science conversation. @katiepalmer.bsky.social has more on scientists' hopes, dreams, and fears for social media:
🩺🧪🧫
Bluesky is the new destination for X/Twitter’s health and science community. Here's why
#MedTwitter is migrating en masse from X to Bluesky, suddenly making it an essential hub for scientific discourse. Here's why.
www.statnews.com
November 21, 2024 at 2:09 PM
Scientists found community on Twitter and stayed because they feared the platform would be full of misinformation if they left.
But Bluesky is now the center of online #medsky and science conversation. @katiepalmer.bsky.social has more on scientists' hopes, dreams, and fears for social media:
🩺🧪🧫
But Bluesky is now the center of online #medsky and science conversation. @katiepalmer.bsky.social has more on scientists' hopes, dreams, and fears for social media:
🩺🧪🧫